These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29080884)

  • 1. [Physicochemical properties of lipopeptide-based liposomes and their complexes with siRNA].
    Turetskiy EA; Koloskova OO; Nosova AS; Shilovskiy IP; Sebyakin YL; Khaitov MR
    Biomed Khim; 2017 Oct; 63(5):472-475. PubMed ID: 29080884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of novel lipopeptide as a vehicle for efficient gene delivery and gene silencing.
    Koloskova OO; Nikonova AA; Budanova UA; Shilovskiy IP; Kofiadi IA; Ivanov AV; Smirnova OA; Zverev VV; Sebaykin YL; Andreev SM; Khaitov MR
    Eur J Pharm Biopharm; 2016 May; 102():159-67. PubMed ID: 26992289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipopeptide structure on gene delivery system properties: Evaluation in 2D and 3D in vitro models.
    Koloskova OO; Gileva AM; Drozdova MG; Grechihina MV; Suzina NE; Budanova UA; Sebyakin YL; Kudlay DA; Shilovskiy IP; Sapozhnikov AM; Kovalenko EI; Markvicheva EA; Khaitov MR
    Colloids Surf B Biointerfaces; 2018 Jul; 167():328-336. PubMed ID: 29684902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anionic amino acid-derived cationic lipid for siRNA delivery.
    Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
    J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
    Wang J; Ayano E; Maitani Y; Kanazawa H
    Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterization of anionic lipid-based ternary siRNA complexes.
    Kapoor M; Burgess DJ
    Biochim Biophys Acta; 2012 Jul; 1818(7):1603-12. PubMed ID: 22465067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation.
    Barichello JM; Ishida T; Kiwada H
    Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
    Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
    Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
    Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chapter 17 - Engineering cationic liposome siRNA complexes for in vitro and in vivo delivery.
    Podesta JE; Kostarelos K
    Methods Enzymol; 2009; 464():343-54. PubMed ID: 19903563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of optimized liposomes for delivery of small interfering RNA.
    Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S
    J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.
    Kapoor M; Burgess DJ
    Int J Pharm; 2012 Aug; 432(1-2):80-90. PubMed ID: 22575754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery.
    Schäfer J; Höbel S; Bakowsky U; Aigner A
    Biomaterials; 2010 Sep; 31(26):6892-900. PubMed ID: 20561681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation.
    Kubota K; Onishi K; Sawaki K; Li T; Mitsuoka K; Sato T; Takeoka S
    Int J Nanomedicine; 2017; 12():5121-5133. PubMed ID: 28790820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopeptide-based micellar and liposomal carriers: Influence of surface charge and particle size on cellular uptake into blood brain barrier cells.
    Sydow K; Nikolenko H; Lorenz D; Müller RH; Dathe M
    Eur J Pharm Biopharm; 2016 Dec; 109():130-139. PubMed ID: 27702684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
    Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
    Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.